128 related articles for article (PubMed ID: 37592047)
21. Risk of chemotherapy-induced febrile neutropenia in intermediate-risk regimens: Clinical and economic outcomes of granulocyte colony-stimulating factor prophylaxis.
Aslam S; Li E; Bell E; Lal L; Anderson AJ; Peterson-Brandt J; Lyman G
J Manag Care Spec Pharm; 2023 Feb; 29(2):128-138. PubMed ID: 36705281
[No Abstract] [Full Text] [Related]
22. Diagnostic Yield of Initial and Consecutive Blood Cultures in Children With Cancer and Febrile Neutropenia.
Haeusler GM; De Abreu Lourenco R; Clark H; Thursky KA; Slavin MA; Babl FE; Mechinaud F; Alvaro F; Clark J; Padhye B; Phillips M; Super L; Tapp H; Walwyn T; Ziegler D; Phillips R; Worth LJ
J Pediatric Infect Dis Soc; 2021 Mar; 10(2):125-130. PubMed ID: 32267508
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of Febrile Neutropenia in Children With Cancer Managed on an Outpatient Basis: A Report From Tertiary Care Hospital From a Resource-limited Setting.
Meena JP; Gupta AK; Seth R
J Pediatr Hematol Oncol; 2020 Nov; 42(8):467-473. PubMed ID: 32815874
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of pegfilgrastim versus filgrastim for prevention of chemotherapy-induced febrile neutropenia in patients with lymphoma: a systematic review.
Gebremariam GT; Fentie AM; Beyene K; Sander B; Gebretekle GB
BMC Health Serv Res; 2022 Dec; 22(1):1600. PubMed ID: 36585648
[TBL] [Abstract][Full Text] [Related]
25. Economic comparison of home-care-based versus hospital-based treatment of chemotherapy-induced febrile neutropenia in children.
Raisch DW; Holdsworth MT; Winter SS; Hutter JJ; Graham ML
Value Health; 2003; 6(2):158-66. PubMed ID: 12641866
[TBL] [Abstract][Full Text] [Related]
26. Prospective audit of post-chemotherapy febrile neutropenia in patients with solid cancer and lymphoma in two Singaporean cancer centres.
Wong M; Jin J; Tan MH; Lee YM; Lee TE; Ding Y; Yong HC; Lim SE; Chai LY; Chau NM; Hsu LY
Ann Acad Med Singap; 2012 Jul; 41(7):287-93. PubMed ID: 22892605
[TBL] [Abstract][Full Text] [Related]
27. The economic value of primary prophylaxis using pegfilgrastim compared with filgrastim in patients with breast cancer in the UK.
Liu Z; Doan QV; Malin J; Leonard R
Appl Health Econ Health Policy; 2009; 7(3):193-205. PubMed ID: 19799473
[TBL] [Abstract][Full Text] [Related]
28. Very early discharge versus early discharge versus non-early discharge in children with cancer and febrile neutropenia.
Loeffen EA; Te Poele EM; Tissing WJ; Boezen HM; de Bont ES
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD008382. PubMed ID: 26899263
[TBL] [Abstract][Full Text] [Related]
29. Retrospective cost analysis of management of febrile neutropenia in cancer patients in Spain.
Mayordomo JI; López A; Viñolas N; Castellanos J; Pernas S; Domingo Alonso J; Frau A; Layola M; Antonio Gasquet J; Sánchez J;
Curr Med Res Opin; 2009 Oct; 25(10):2533-42. PubMed ID: 19722781
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the MASCC and CISNE scores for identifying low-risk neutropenic fever patients: analysis of data from three emergency departments of cancer centers in three continents.
Ahn S; Rice TW; Yeung SJ; Cooksley T
Support Care Cancer; 2018 May; 26(5):1465-1470. PubMed ID: 29168032
[TBL] [Abstract][Full Text] [Related]
31. Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective study.
Ahmed N; El-Mahallawy HA; Ahmed IA; Nassif S; El-Beshlawy A; El-Haddad A
Pediatr Blood Cancer; 2007 Nov; 49(6):786-92. PubMed ID: 17366527
[TBL] [Abstract][Full Text] [Related]
32. A prediction model for bacteremia and transfer to intensive care in pediatric and adolescent cancer patients with febrile neutropenia.
Alali M; Mayampurath A; Dai Y; Bartlett AH
Sci Rep; 2022 May; 12(1):7429. PubMed ID: 35523855
[TBL] [Abstract][Full Text] [Related]
33. Direct costs associated with febrile neutropenia in inpatients with hematological diseases in Singapore.
Zhou YP; Jin J; Ding Y; Chee YL; Koh LP; Chng WJ; Chan DS; Hsu LY
Support Care Cancer; 2014 Jun; 22(6):1447-51. PubMed ID: 24287505
[TBL] [Abstract][Full Text] [Related]
34. Economic costs of chemotherapy-induced febrile neutropenia among patients with non-Hodgkin's lymphoma in European and Australian clinical practice.
Weycker D; Danel A; Marciniak A; Bendall K; Lipsitz M; Pettengell R
BMC Cancer; 2012 Aug; 12():362. PubMed ID: 22913768
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of direct medical costs of hospitalization for febrile neutropenia.
Lathia N; Mittmann N; DeAngelis C; Knowles S; Cheung M; Piliotis E; Shear N; Walker S
Cancer; 2010 Feb; 116(3):742-8. PubMed ID: 20029970
[TBL] [Abstract][Full Text] [Related]
36. Can Risk Stratification Tools Be Utilized to Safely Discharge Low-Risk Febrile Neutropenic Patients from the Emergency Department?
Chen AY; Gottlieb M; Vilke GM; Coyne C
J Emerg Med; 2023 Jan; 64(1):111-118. PubMed ID: 36641256
[TBL] [Abstract][Full Text] [Related]
37. The economics of febrile neutropenia: implications for the use of colony-stimulating factors.
Lyman GH; Kuderer N; Greene J; Balducci L
Eur J Cancer; 1998 Nov; 34(12):1857-64. PubMed ID: 10023306
[TBL] [Abstract][Full Text] [Related]
38. Predictive Factors of Severe Adverse Events in Pediatric Oncologic Patients with Febrile Neutropenia.
Thangthong J; Anugulruengkitt S; Lauhasurayotin S; Chiengthong K; Poparn H; Sosothikul D; Techavichit P
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3487-3492. PubMed ID: 33369443
[TBL] [Abstract][Full Text] [Related]
39. Emergency department management of chemotherapy related febrile neutropenia: An opportunity to improve care.
Pettit N; Boadu D; Bischof JJ
Am J Emerg Med; 2021 Dec; 50():5-9. PubMed ID: 34265732
[TBL] [Abstract][Full Text] [Related]
40. Emergency Ambulatory Management of Low-Risk Febrile Neutropenia: Multinational Association for Supportive Care in Cancer Fits-Real-World Experience From a UK Cancer Center.
Marshall W; Campbell G; Knight T; Al-Sayed T; Cooksley T
J Emerg Med; 2020 Mar; 58(3):444-448. PubMed ID: 31744709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
